Carina Vieira Dias
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Carina Vieira Dias has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Ana Luísa De Sousa-Coelho
Algarve Biomedical Center Research Institute (ABC-RI), Universidade do Algarve, 8005-139 Faro, Portugal
2 shared publications - Joana C. Dias
Escola Superior de Saúde, Universidade do Algarve (ESSUAlg), 8005-139 Faro, Portugal
2 shared publications - Ana Lúcia Silva
Insight: Piaget Research Center for Ecological Human Development, Instituto Piaget, 2805-059 Almada, Portugal
1 shared publication - Andreia Fernandes
Unidade Local de Saúde do Algarve (ULSALG), Unidade de Faro, Serviço de Cirurgia, Rua Leão Penedo, 8000-286 Faro, Portugal
1 shared publication - Céu Laranjo
Centro Hospitalar Universitário do Algarve (CHUA), 8000-386 Faro, Portugal
1 shared publication - Filipa Nunes
Unidade Local de Saúde do Algarve (ULSALG), Unidade de Faro, Serviço de Cirurgia, Rua Leão Penedo, 8000-286 Faro, Portugal
1 shared publication
Latest Publications
- Open Access
- 2 January 2025
- Published by MDPI AG in Clinics and Practice
- Vol. 15 (1) , 11
Comparing International Guidelines for the Remission of Hypertension After Bariatric Surgery
Background/Objectives: Obesity remains a global health concern and is associated with increased risk of type 2 diabetes, hypertension, and cardiovascular disease overall. Dissimilar hypertension guidelines are available for clinicians, namely those prepared by the American Heart Association (AHA) and the European Society of Cardiology (ESC), which may lead to distinctive appreciation of health outcomes of patients with obesity after bariatric and metabolic surgery, such as hypertension remission. The main goal of this study was to compare the effects of applying stricter (AHA) versus looser (ESC) blood pressure criteria on hypertension diagnosis pre-bariatric surgery and remission assessment one year post-op. Methods: A retrospective analysis of clinical data from patients who underwent surgical treatment for obesity at a single university hospital was performed. To evaluate the hypertension improvement or remission, two different types of blood pressure (BP) categorization were considered (based on AHA and ESC guidelines), in which each patient would fit according to their BP values pre- (m0) and 12 months postoperative (m12). Results: From a sample of 153 patients submitted for surgical treatment of obesity, more patients were considered with hypertension based on the AHA guideline (130 vs. 102; p < 0.001), while a higher rate of hypertension remission at 12 months after bariatric surgery was observed when following the ESC guideline (58.82 vs. 53.08%). Baseline patients’ clinical characteristics based on each hypertension outcome were mostly independent of the guideline used (p > 0.05), where only age and systolic blood pressure were relatively higher in “ESC groups”. Conclusions: We conclude that only minor differences exist between the two guidelines used. If evaluated based on ESC guidelines, it is expected that less patients are considered with hypertension, and the remission rate may be, at least numerically, higher.
- 2 January 2025
- Published by MDPI AG in Clinics and Practice
- Vol. 15 (1) , 11
Open AccessComparing International Guidelines for the Remission of Hypertension After Bariatric Surgery
Background/Objectives: Obesity remains a global health concern and is associated with increased risk of type 2 diabetes, hypertension, and cardiovascular disease overall. Dissimilar hypertension guidelines are available for clinicians, namely those prepared by the American Heart Association (AHA) and the European Society of Cardiology (ESC), which may lead to distinctive appreciation of health outcomes of patients with obesity after bariatric and metabolic surgery, such as hypertension remission. The main goal of this study was to compare the effects of applying stricter (AHA) versus looser (ESC) blood pressure criteria on hypertension diagnosis pre-bariatric surgery and remission assessment one year post-op. Methods: A retrospective analysis of clinical data from patients who underwent surgical treatment for obesity at a single university hospital was performed. To evaluate the hypertension improvement or remission, two different types of blood pressure (BP) categorization were considered (based on AHA and ESC guidelines), in which each patient would fit according to their BP values pre- (m0) and 12 months postoperative (m12). Results: From a sample of 153 patients submitted for surgical treatment of obesity, more patients were considered with hypertension based on the AHA guideline (130 vs. 102; p < 0.001), while a higher rate of hypertension remission at 12 months after bariatric surgery was observed when following the ESC guideline (58.82 vs. 53.08%). Baseline patients’ clinical characteristics based on each hypertension outcome were mostly independent of the guideline used (p > 0.05), where only age and systolic blood pressure were relatively higher in “ESC groups”. Conclusions: We conclude that only minor differences exist between the two guidelines used. If evaluated based on ESC guidelines, it is expected that less patients are considered with hypertension, and the remission rate may be, at least numerically, higher.
- Open Access
- 17 April 2024
- Published by MDPI AG in Proceedings
- Vol. 99 (1) , 11
On the Run—Comparing Bioimpedance Analysis (BIA) Using Portable Devices
Bioelectrical impedance analysis (BIA) is a non-invasive indirect method that allows for measurement of lean and fat body mass. The main goal of this exploratory study was to compare the results from two different portable BIA devices. We found that only fat-free mass and body fat mass were directly comparable between InBodyS10 (Teprel, Porto, Portugal) and seca mBCA 525 (Bacelar, Porto, Portugal) medical portable BIA devices.
- 17 April 2024
- Published by MDPI AG in Proceedings
- Vol. 99 (1) , 11
Open AccessOn the Run—Comparing Bioimpedance Analysis (BIA) Using Portable Devices
Bioelectrical impedance analysis (BIA) is a non-invasive indirect method that allows for measurement of lean and fat body mass. The main goal of this exploratory study was to compare the results from two different portable BIA devices. We found that only fat-free mass and body fat mass were directly comparable between InBodyS10 (Teprel, Porto, Portugal) and seca mBCA 525 (Bacelar, Porto, Portugal) medical portable BIA devices.